Matricelf Ltd Cash Flow Conversion Efficiency

Latest as of June 2025: -997.589x

Matricelf Ltd cash flow conversion efficiency. Based on the latest financial reports, Matricelf Ltd (MTLF) has a cash flow conversion efficiency ratio of -997.589x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-8.28 Million ≈ $-22.18K USD) by net assets (ILA8.29K ≈ $22.24 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Matricelf Ltd (2019–2024)

Cash flow conversion efficiency of Matricelf Ltd from 2019 to 2024. This chart illustrates how Matricelf Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Matricelf Ltd for real-time trading data and today's change.

Matricelf Ltd Cash Flow Conversion Ratio Explained

Matricelf Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Matricelf Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Matricelf Ltd ranked by their cash flow conversion efficiency. Also see Matricelf Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
SCI Electric Public Company Limited
BK:SCI
0.031x
Coats Group PLC
LSE:COA
0.184x
Jacques Bogart SA
PA:JBOG
0.688x
Music Broadcast Limited
NSE:RADIOCITY
0.017x
Black Hawk Acquisition Corporation
NASDAQ:BKHA
-0.012x
Genius Group Ltd
NYSE MKT:GNS
-0.103x
Alumil Rom Industry SA
RO:ALU
0.117x
Mene Inc
V:MENE
0.048x

Annual Cash Flow Conversion Efficiency for Matricelf Ltd (2019–2024)

The table below shows the annual cash flow conversion efficiency of Matricelf Ltd from 2019 to 2024. Review MTLF free cash flow debt coverage to assess the company's free cash flow relative to its total liabilities.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ILA15.17 Million
≈ $40.66K
ILA-11.75K
≈ $-31.51
-0.001x -98.09%
2023-12-31 ILA26.80 Million
≈ $71.86K
ILA-10.49K
≈ $-28.12
0.000x +99.83%
2022-12-31 ILA35.79 Million
≈ $95.96K
ILA-8.30 Million
≈ $-22.25K
-0.232x +8.20%
2021-12-31 ILA26.23 Million
≈ $70.32K
ILA-6.62 Million
≈ $-17.76K
-0.253x +79.57%
2020-12-31 ILA2.80 Million
≈ $7.50K
ILA-3.46 Million
≈ $-9.27K
-1.236x -1354.61%
2019-12-31 ILA3.62 Million
≈ $9.71K
ILA-307.80K
≈ $-825.19
-0.085x --

About Matricelf Ltd

TA:MTLF Israel Biotechnology
Market Cap
$19.61 Million
ILA7.31 Billion ILA
Market Cap Rank
#25037 Global
#362 in Israel
Share Price
ILA250.10
Change (1 day)
+1.87%
52-Week Range
ILA227.10 - ILA785.80
All Time High
ILA1480.00
About

Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. The company's regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson's disease, and myocardial infarction, as well as for 3D bioprinting. Matricelf Ltd was incorporated in 20… Read more